WO2004056374A8 - Use of glycyrrhizin for the treatment of standard therapy-resistant hepatitis c patients - Google Patents

Use of glycyrrhizin for the treatment of standard therapy-resistant hepatitis c patients

Info

Publication number
WO2004056374A8
WO2004056374A8 PCT/EP2003/014825 EP0314825W WO2004056374A8 WO 2004056374 A8 WO2004056374 A8 WO 2004056374A8 EP 0314825 W EP0314825 W EP 0314825W WO 2004056374 A8 WO2004056374 A8 WO 2004056374A8
Authority
WO
WIPO (PCT)
Prior art keywords
glycyrrhizin
treatment
patients
standard therapy
resistant hepatitis
Prior art date
Application number
PCT/EP2003/014825
Other languages
French (fr)
Other versions
WO2004056374A1 (en
Inventor
Kyozo Utsunomiya
Original Assignee
Hpc Healthcare & Pharma Consul
Minophagen Pharmaceutical Co L
Kyozo Utsunomiya
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hpc Healthcare & Pharma Consul, Minophagen Pharmaceutical Co L, Kyozo Utsunomiya filed Critical Hpc Healthcare & Pharma Consul
Priority to AU2003300550A priority Critical patent/AU2003300550A1/en
Publication of WO2004056374A1 publication Critical patent/WO2004056374A1/en
Publication of WO2004056374A8 publication Critical patent/WO2004056374A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Abstract

The invention relates to the use of glycyrrhizin and metabolites thereof for the treatment of standard therapy resistant Hepatitis C virus infections.
PCT/EP2003/014825 2002-12-23 2003-12-23 Use of glycyrrhizin for the treatment of standard therapy-resistant hepatitis c patients WO2004056374A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003300550A AU2003300550A1 (en) 2002-12-23 2003-12-23 Use of glycyrrhizin for the treatment of standard therapy-resistant hepatitis c patients

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02028803.1 2002-12-23
EP02028803 2002-12-23

Publications (2)

Publication Number Publication Date
WO2004056374A1 WO2004056374A1 (en) 2004-07-08
WO2004056374A8 true WO2004056374A8 (en) 2004-12-16

Family

ID=32668742

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/014825 WO2004056374A1 (en) 2002-12-23 2003-12-23 Use of glycyrrhizin for the treatment of standard therapy-resistant hepatitis c patients

Country Status (2)

Country Link
AU (1) AU2003300550A1 (en)
WO (1) WO2004056374A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102209897B (en) 2008-09-11 2015-04-29 巴斯德研究院 Monitoring and inhibiting human immunodeficiency virus infection by modulating hmgb1 dependent triggering of hiv-1 replication and persistence

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2717964B2 (en) * 1987-10-16 1998-02-25 丸善製薬株式会社 Method for producing glycyrrhizin
JPH03255037A (en) * 1990-03-02 1991-11-13 Santen Pharmaceut Co Ltd Glycyrrhizin pharmaceutical preparation

Also Published As

Publication number Publication date
WO2004056374A1 (en) 2004-07-08
AU2003300550A1 (en) 2004-07-14

Similar Documents

Publication Publication Date Title
WO2003072035A8 (en) Compositions and methods for the treatment of immune related diseases
WO2004041170A9 (en) Compositions and methods for the treatment of immune related diseases
EP1492563A4 (en) Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
EP1572095A4 (en) S-l-2 -deoxynucleosides for the treatment of resistant hbv strains and combination therapies
ZA200410229B (en) Administration of therapeutic viruses
WO2004024097A9 (en) Compositions and methods for the treatment of immune related diseases
AU2003231866A1 (en) Herbs and herbal combinations useful for the treatment of microbial infections
PL376454A1 (en) 1-acyl-pyrrolidine derivatives for the treatment of viral infections
AU2002303502A1 (en) Improved leads for the treatment of patients with chf
AUPR839001A0 (en) Dosage form, device and methods of treatment
EP1765330A4 (en) Pyranoindole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease
ZA200303037B (en) Herbal pharmaceutical composition for treatment of HIV/Aids patients.
AU2002347152A1 (en) Immune globulin formulations for the treatment and prevention of an orthopoxvirus infection
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
AU2003210659A1 (en) Combination therapy for treatment of hiv infection
AU2002322082A1 (en) Pharmaceutical composition for the treatment of viral infection
TWI347845B (en) Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
AU2002325169A1 (en) Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
AU2003249930A1 (en) Proteaseome inhibitors for the treatment of herpesviridae infected individuals
WO2004024076A8 (en) Novel compositions and methods for the treatment of immune related diseases
WO2004056374A8 (en) Use of glycyrrhizin for the treatment of standard therapy-resistant hepatitis c patients
AU2003237088A1 (en) Compounds, compositions and methods for treating or preventing viral infections and associated diseases
AU2002332613A1 (en) Compositions and therapeutic methods for viral infection
AU2002323443A1 (en) Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
AU2003287216A1 (en) Gb virus c and methods of treating viral infections

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 28/2004 UNDER (71) REPLACE "(FOR US ONLY)" BY "(FOR ALL DESIGNATED STATES EXCEPT US)"

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP